Condition: Dry Eye · Sponsor: Vanda Pharmaceuticals
Interested? Contact the study team ↓
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
This description comes directly from the study's public registry record.
Vanda Pharmaceuticals · 202-734-3400 · clinicaltrials@vandapharma.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Be at least 18 years of age of either gender and any race. * Provide written informed consent and sign the HIPAA form. * Be willing and able to follow all instructions and attend all study visits. Exclusion Criteria: * Use of any of the disallowed medications during the washout and study period.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Vanda Investigational Site | Newport Beach, California, United States | Recruiting |
| Vanda Investigational Site | Andover, Massachusetts, United States | Not Yet Recruiting |
| Vanda Investigational Site | Shelby, North Carolina, United States | Not Yet Recruiting |
| Vanda Investigational Site | Memphis, Tennessee, United States | Recruiting |
| Vanda Investigational Site | Lynchburg, Virginia, United States | Not Yet Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.